Recent advancements in diabetes treatment have brought forth a new generation of drugs known as GLP-1 receptor agonists. These compounds work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a hormone that https://tomasbrkx979206.blogdigy.com/the-latest-in-glp-1-receptor-agonists-retaglutide-retatrutide-and-tirzepatide-61384346